The Journal of Immunology, Vol 142, Issue 2 590-595, Copyright © 1989 by American Association of Immunologists

ARTICLES

The human B lymphocyte and carcinoma antigen, CDw40, is a phosphoprotein involved in growth signal transduction

S Paulie, A Rosen, B Ehlin-Henriksson, S Braesch-Andersen, E Jakobson, H Koho and P Perlmann
Department of Immunology, University of Stockholm, Sweden.

The human B lymphocyte and carcinoma-associated Ag, CDw40, (p50, Bp50) is a receptor candidate for normal growth regulation. Interaction of mAb with this pan-B Ag, together with preactivating agents such as 12-O- tetradecanoylphorbol-13-acetate or anti-mu, deliver strong growth- promoting signals to the cells. We here demonstrate that signaling through this Ag is dependent on its aggregation on the cell surface. Thus, monovalent antibody fragments were relatively inefficient in this respect but effectively blocked stimulation by intact antibody. By using affinity purified CDw40 protein we have also demonstrated that it is antigenically distinct from other B cell-associated Ag, including the six differentiation clusters CD19 to CD24. The mAb S2C6 and G28.5, prepared by immunizing mice with human bladder carcinoma cells or tonsillar B-cells, respectively, were the only antibodies giving detectable binding. Either of these antibodies could also completely block the binding of the other, suggesting an identity or structural proximity of the epitopes recognized. The CDw40 Ag was shown to be a phosphoprotein lacking intrinsic protein kinase activity. The results provide further evidence for CDw40 being an important B cell growth factor receptor which may also have growth regulatory functions in the development of certain human carcinomas.

This article has been cited by other articles:

				J. K. Lee, S. O. Mathew, S. V. Vaidya, P. R. Kumaresan, and P. A. Mathew CS1 (CRACC, CD319) Induces Proliferation and Autocrine Cytokine Expression on Human B Lymphocytes J. Immunol., October 1, 2007; 179(7): 4672 - 4678. [Abstract] [Full Text] [PDF]

				A. M. Merendino, F. Bucchieri, R. Gagliardo, A. Daryadel, F. Pompeo, G. Chiappara, R. Santagata, V. Bellia, S. David, F. Farina, et al. CD40 Ligation Protects Bronchial Epithelium against Oxidant-Induced Caspase-Independent Cell Death Am. J. Respir. Cell Mol. Biol., August 1, 2006; 35(2): 155 - 164. [Abstract] [Full Text] [PDF]

				J. Kaufman, P. J. Sime, and R. P. Phipps Expression of CD154 (CD40 Ligand) by Human Lung Fibroblasts: Differential Regulation by IFN-{gamma} and IL-13, and Implications for Fibrosis J. Immunol., February 1, 2004; 172(3): 1862 - 1871. [Abstract] [Full Text] [PDF]

				S. A. Haxhinasto, B. S. Hostager, and G. A. Bishop Cutting Edge: Molecular Mechanisms of Synergy Between CD40 and the B Cell Antigen Receptor: Role for TNF Receptor-Associated Factor 2 in Receptor Interaction J. Immunol., August 1, 2002; 169(3): 1145 - 1149. [Abstract] [Full Text] [PDF]

				A. W. Tong, M. H. Papayoti, G. Netto, D. T. Armstrong, G. Ordonez, J. M. Lawson, and M. J. Stone Growth-inhibitory Effects of CD40 Ligand (CD154) and Its Endogenous Expression in Human Breast Cancer Clin. Cancer Res., March 1, 2001; 7(3): 691 - 703. [Abstract] [Full Text]

				T. Bloss, A. Kaykas, and B. Sugden Dissociation of patching by latent membrane protein-1 of Epstein-Barr virus from its stimulation of NF-{kappa}B activity J. Gen. Virol., December 1, 1999; 80(12): 3227 - 3232. [Abstract] [Full Text]

				L. Biancone, V. Cantaluppi, M. Boccellino, L. Del Sorbo, S. Russo, A. Albini, I. Stamenkovic, and G. Camussi Activation of CD40 Favors the Growth and Vascularization of Kaposi's Sarcoma J. Immunol., December 1, 1999; 163(11): 6201 - 6208. [Abstract] [Full Text] [PDF]

				M. R. Kuhne, M. Robbins, J. E. Hambor, M. F. Mackey, Y. Kosaka, T. Nishimura, J. P. Gigley, R. J. Noelle, and D. M. Calderhead Assembly and Regulation of the CD40 Receptor Complex in Human B Cells J. Exp. Med., July 21, 1997; 186(2): 337 - 342. [Abstract] [Full Text] [PDF]